Veloxis Pharmaceuticals A/S - Company & Market Research Reports

Veloxis Pharmaceuticals is a commercial-stage specialty pharmaceutical company that operates in Europe and the United States. Veloxis’ products include tacrolimus extended-release tablets called Envarsus XR and MeltDose, which is designed to enhance the absorption and bioavailability of select orally administered drugs. The company was formerly known as LifeCycle Pharma A/S and changed its name to Veloxis Pharmaceuticals A/S in July 2011. Veloxis is based in Copenhagen, Denmark.


Liver Transplant Rejection - Pipeline Review, H1 2018 - Product Thumbnail Image

Liver Transplant Rejection - Pipeline Review, H1 2018

  • Report
  • 72 Pages
From
Envarsus XR 2016 U.S Promotional Report - Product Thumbnail Image

Envarsus XR 2016 U.S Promotional Report

  • Report
  • 26 Pages
From
Anti-Rejection Drugs for Special Conditions - Global Markets - Product Thumbnail Image

Anti-Rejection Drugs for Special Conditions - Global Markets

  • Report
  • 179 Pages
Bioavailability Enhancement Technologies and Services Market, 2018-2030 - Product Thumbnail Image

Bioavailability Enhancement Technologies and Services Market, 2018-2030

  • Report
  • 300 Pages
From
Organ and Tissue Transplantation - Global Strategic Business Report - Product Thumbnail Image

Organ and Tissue Transplantation - Global Strategic Business Report

  • Report
  • 275 Pages
From
Autoimmune Hepatitis Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Autoimmune Hepatitis Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 51 Pages
From
Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas - Product Thumbnail Image

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

  • Report
  • 540 Pages
From
Veloxis Pharmaceuticals AS (VELO) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Veloxis Pharmaceuticals AS (VELO) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 42 Pages
From
Veloxis Pharmaceuticals A/S Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report - Product Thumbnail Image

Veloxis Pharmaceuticals A/S Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

  • Financial Report
  • 35 Pages
From
Veloxis Pharmaceuticals A/S - Product Thumbnail Image

Veloxis Pharmaceuticals A/S

  • Company Profile
  • 69 Pages
Veloxis Pharmaceuticals A/S Strategic Analysis Review - Veloxis Pharmaceuticals A/S SWOT, Outlook, Operations and Financial Profile - Product Thumbnail Image

Veloxis Pharmaceuticals A/S Strategic Analysis Review - Veloxis Pharmaceuticals A/S SWOT, Outlook, Operations and Financial Profile

  • Company Profile
  • 30 Pages
From
Q2 2017 Earnings Call - Veloxis Pharmaceuticals A/S, - Earnings Transcript - Product Thumbnail Image

Q2 2017 Earnings Call - Veloxis Pharmaceuticals A/S, - Earnings Transcript

  • Earnings Transcript
Veloxis AS Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Veloxis AS Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
Veloxis A/S Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Veloxis A/S Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
Q4 2016 Earnings Call - Veloxis Pharmaceuticals A/S, - Earnings Transcript - Product Thumbnail Image

Q4 2016 Earnings Call - Veloxis Pharmaceuticals A/S, - Earnings Transcript

  • Earnings Transcript
Q4 2014 Earnings Call - Veloxis Pharmaceuticals A/S, - Earnings Transcript - Product Thumbnail Image

Q4 2014 Earnings Call - Veloxis Pharmaceuticals A/S, - Earnings Transcript

  • Earnings Transcript
  • 16 Results (Page 1 of 1)
Loading Indicator
adroll